SE393377B - Sett att framstella morfolinderivat - Google Patents

Sett att framstella morfolinderivat

Info

Publication number
SE393377B
SE393377B SE7008505A SE850570A SE393377B SE 393377 B SE393377 B SE 393377B SE 7008505 A SE7008505 A SE 7008505A SE 850570 A SE850570 A SE 850570A SE 393377 B SE393377 B SE 393377B
Authority
SE
Sweden
Prior art keywords
way
morpholine derivatives
produce
produce morpholine
derivatives
Prior art date
Application number
SE7008505A
Other languages
English (en)
Swedish (sv)
Inventor
S A Lee
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB5013069A external-priority patent/GB1260886A/en
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of SE393377B publication Critical patent/SE393377B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Monitoring And Testing Of Nuclear Reactors (AREA)
SE7008505A 1969-06-20 1970-06-18 Sett att framstella morfolinderivat SE393377B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5013069A GB1260886A (en) 1969-06-20 1969-06-20 Process for aryloxymethylmorpholine derivatives
GB3125569 1969-06-20

Publications (1)

Publication Number Publication Date
SE393377B true SE393377B (sv) 1977-05-09

Family

ID=26260810

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7008505A SE393377B (sv) 1969-06-20 1970-06-18 Sett att framstella morfolinderivat

Country Status (9)

Country Link
US (1) US3712890A (fr)
JP (1) JPS5016795B1 (fr)
CH (1) CH539068A (fr)
ES (1) ES380973A1 (fr)
FI (1) FI61890C (fr)
HU (1) HU162422B (fr)
NO (1) NO135939C (fr)
SE (1) SE393377B (fr)
YU (2) YU35009B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857839A (en) * 1969-06-20 1974-12-31 Ici Ltd For cyclising 1-aryloxy-3 beta-substituted ethylamino-2-propanols
GB1427097A (en) * 1973-10-18 1976-03-03 Ici Ltd Optically-active morpholine derivatives
JPS5939437B2 (ja) * 1975-05-08 1984-09-22 ウェルファイド株式会社 モルホリン誘導体の製造法
JPS51146900U (fr) * 1975-05-20 1976-11-25
US4005084A (en) * 1975-07-10 1977-01-25 Yoshitomi Pharmaceutical Industries, Ltd. Thienylmethyl phenoxy morpholine compounds
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
US4351848A (en) * 1978-03-16 1982-09-28 Drug Science Foundation 1-((1-Methylethyl)amino)-3-(((4-alkylthio)1-naphthalenyl)oxy)-2-propanol
US4342783A (en) * 1980-06-30 1982-08-03 Synthelabo Anti-glaucoma agent
US4396629A (en) * 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method
JPS59167545U (ja) * 1983-04-25 1984-11-09 伊藤　秀雄 中高層建築物用人命救助具
CA2522666A1 (fr) * 2003-04-18 2004-10-28 Pharmacia & Upjohn Company Llc Polytherapies
MX357614B (es) 2010-04-12 2018-07-17 Supernus Pharmaceuticals Inc Métodos para producir sales de viloxazina y polimorfos novedosos de las mismas.
CN118451064A (zh) 2022-03-18 2024-08-06 苏佩努斯制药公司 制备取代吗啉的衍生物的方法
WO2023248154A1 (fr) * 2022-06-22 2023-12-28 Glenmark Life Sciences Limited Procédé de préparation de chlorhydrate de viloxazine
EP4317141A1 (fr) 2022-08-04 2024-02-07 Curia Spain S.A.U. Procédé et intermédiaires pour la préparation de viloxazine et d'autres dérivés de morpholine substitués en 2

Also Published As

Publication number Publication date
YU35009B (en) 1980-06-30
NO135939B (fr) 1977-03-21
FI61890C (fi) 1982-10-11
NO135939C (fr) 1977-07-06
ES380973A1 (es) 1973-04-16
YU40208B (en) 1985-08-31
HU162422B (fr) 1973-02-28
JPS5016795B1 (fr) 1975-06-16
YU155370A (en) 1979-12-31
US3712890A (en) 1973-01-23
YU268978A (en) 1982-10-31
FI61890B (fi) 1982-06-30
CH539068A (de) 1973-07-15

Similar Documents

Publication Publication Date Title
SE383159B (sv) Sett att framstella vesikuler polymer
SE412586B (sv) Sett att framstella isoflavonderivat
SE385701B (sv) Sett att framstella 1,4-bensodiazepinderivat
SE385889B (sv) Sett att framstella morfolinderivat
SE393377B (sv) Sett att framstella morfolinderivat
SE421690B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE382215B (sv) Sett att framstella kromanderivat
SE391181B (sv) Sett att framstella kinazolinderivat
SE387337B (sv) Sett att framstella nya tiokarbamidsyraderivat
SE399255B (sv) Sett att framstella kinazolinonderivat
SE7603276L (sv) Sett att framstella prostansyraderivat
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE417981B (sv) Sett att framstella cefalosporinforeningar
SE381257B (sv) Sett att framstella rifamycinderivat
SE420087B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE400078B (sv) Sett att framstella kinazolinonderivat
SE405966B (sv) Sett att framstella peptider
SE397679B (sv) Sett att framstella kinazolinonderivat
SE399712B (sv) Sett att framstella pregnansyraderivat
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE400281B (sv) Sett att framstella kinazolinonderivat
SE401184B (sv) Sett att framstella morfolinderivat
SE390301B (sv) Sett att framstella butyrfenonederivat
SE387632B (sv) Sett att framstella nya 3-amino-delta?722-pyrazolinderivat
SE417830B (sv) Sett att framstella vissa sulfonylmetylsubstituerade bicykloalkanoner